(MedPage Today) — The use of base editing to generate universal off-the-shelf CAR T cells induced durable remissions — up to 36 months in one case — in patients with relapsed or refractory T-cell acute lymphoblastic leukemia (ALL), according…
Source link : https://www.medpagetoday.com/hematologyoncology/leukemia/119346
Author :
Publish date : 2026-01-08 22:44:00
Copyright for syndicated content belongs to the linked Source.
